Norway· NO-ID_FA3D6BA5-44D1-4E51-86F3-D61A40C7AD35
Bydureon
A exenatide product containing eksenatid, registered in Norway by AstraZeneca. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Exenatide is registered in 10 of 19 countries.
Countries holding a registration under ATC A10BJ01 (exenatide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Exenatide · ATC A10BJ01
10 / 19 countries
- Belgiumprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of exenatide costs, country by country.
Normalised to the WHO defined daily dose (15 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Exenatide · price per daily dose (15 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$0.26
The record
At a glance
FEST (Norway)- Active substance
- Eksenatid
- Manufacturer
- AstraZeneca
- Country
- Norway (NO)
- ATC code
- A10BJ01
- ATC class
- Exenatide
- Defined daily dose
- 15 mcg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_FA3D6BA5-44D1-4E51-86F3-D61A40C7AD35
- no_varenummer2630284 x 0.85
- gtin4150160155419
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
404 interactions on record for exenatide.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Exenatide · interactions on record
404 records
- 3 severe
- 359 moderate
- 42 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- MannitolA06AD16moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Exenatide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBydureon 2 mgAstraZeneca
- SpainBYDUREON 2 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN PLUMA PRECARGADAAstrazeneca Ab
- United KingdomBydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pensAstraZeneca UK Ltd
- United StatesByettaAstraZeneca Pharmaceuticals LP
- FinlandBydureonAstraZeneca AB
- IrelandBydureon 2 mg powder and solvent for prolonged-release suspension for injectionAstraZeneca AB
- ItalyBYDUREON*4 penne preriempite Bcise SC 2 mg 0,85 ml rilascio prolungatoASTRAZENECA AB
- PolandBydureonAstraZeneca AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1584d21-e5fe-438f-993c-797abd33a96f GET /v1/drugs/c1584d21-e5fe-438f-993c-797abd33a96f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Depotinjeksjonsvæske, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Eksenatid",
"merkevare_id": "ID_FA3D6BA5-44D1-4E51-86F3-D61A40C7AD35",
"name_form_strength": "Bydureon depotinj væske, susp 2 mg/penn",
"prescription_group": "C"
}See everything about exenatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.